About ORYN THERAPEUTICS, INC.
Oryn Therapeutics is a biotechnology company focused on developing macrocyclic peptide therapeutics, specifically Orynotides™, designed to reprogram immune networks in chronic inflammatory and autoimmune diseases. The company's platform targets complex biological pathways that are difficult to modulate with traditional therapies.
Development of macrocyclic peptide therapeutics (Orynotides™)Immune reprogramming through modulation of interconnected inflammatory networksEngineering of cell-permeable peptides that target both extracellular and intracellular biological targetsSelective modulation of disease drivers in inflammatory, autoimmune, and fibrotic conditions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ORYN THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.